Skip to content

COMPARING THE EFFECT OF TOPICAL APPLICATION OF ELEPHANT CREEPER AND TULSI GEL ALONG WITH SCALING IN TREATMENT OF GINGIVITIS.

COMPARATIVE EVALUATION OF TOPICAL APPLICATION OF ARGYREIA SPECIOSA GEL AND OCIMUM SANCTUM GEL AS AN ADJUNCT TO SCALING IN TREATMENT OF GINGIVITIS: A RANDOMISED CONTROLLED CLINICAL TRIAL. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097787
Enrollment
45
Registered
2025-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: Topical Application of Argyreia Speciosa Gel as an adjunct to scaling: After scaling patients will be asked to apply topical application of Argyreia Speciosa Gel 2 times a day for

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Chronic gingivitis patients with a minimum of 16 gradable teeth. 2) Systemically healthy patients. 3) Patients requiring scaling. 4) Both males and females between the age group of 20-60 year with less than or equal to 3 mm of probing depth (PD). 5) Availability of the patient for the entire duration of the study. 6) Patient should be able to understand and give a written informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with history of deleterious habits (i.e., use of tobacco consumption etc.) 2) Patients with systemic diseases (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases). 3) Patients on systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy prescribed or received within 2 months prior to study entry. 4) Pregnant and/or lactating females. 5) Patients contraindicated for scaling. 6) Patient on systemic antibiotics for the past 3 months. 7) Use of anti-inflammatory drugs within the past 3 months. 8) Patient receiving periodontal treatment within last 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in gingival inflammation and plaque formation.Timepoint: BASELINE AND AFTER 15 DAYS

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Kaushik Sunil Kothimbire

SMBT Dental College and Hospital Sangamner

dr.saurabh.subhash.patil@gmail.com9325596570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026